Abstract
Drug discovery is an interdisciplinary endeavor that has greatly benefited from advances in chemistry, pharmacology, microbiology, biology and biochemistry. The process of bringing a molecule to the marketplace is very complex, time-consuming and expensive. To remain competitive in the industry, the pharmaceutical company is forced to adopt new technologies to shorten the time required for drug discovery and development. Recent advances in genomics, combinatorial chemistry, high throughput screening and biochip technology are having a revolutionary impact on various stages of the drug discovery process. The synergy among these fields is emerging. However, a common challenge to researchers in each of these fields is how to turn the massive raw data that have been accumulating at an explosive rate into useful information and knowledge in order to more efficiently guide the process of drug discovery. This chapter addresses the needs and commonalities of data mining in these areas. The principles of these technologies are briefly described at first, followed by a discussion of the rational integration of data mining tools into pharmaceutical research. Advances in the analysis of massive gene chip data are also discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Blair RM, Fang H, Branham WS, Hass BS, Dial SL, Moland CL, Tong W, Shi L, Perkins R and Sheehan DM (2000) Toxicol Sci 54: 138–153
Charifson PS (ed.) (1997) Practical Application of Computer-Aided Drug Design, Marcel Dekker, New York
Cox B, Denyer JC, Binnie A, Donnelly MC, Evans B, Green DV, Lewis JA, Mander TH, Merritt AT, Valler MJ and Watson SP (2000) Prog Med Chem 37: 83–133
Cramer III RD, Patterson DE and Bunce JD (1988) J Amer Chem Soc 110: 59–5967
Dean PM and Lewis RA (eds) (1999) Molecular Diversity in Drug Design, Kluwer, Dordrecht
Dixon SL and Villar HO (1998) J Chem Inf Comput. Science 38: 1192–1203
Drews J (2000) Science 1960–1964
Eisen MB, Spellman PT, Brown PO and Botstein D (1998) Proc Natl Acad Sci (USA). 95: 14863–14868
EPA’s Endocrine Disruptor Screening and Testing Advisory Committee (EDSTAC) (1998) Final Report, http://www.epa.gov/scipoly/oscpendo/history/finalrpt.htm
Evans WE and Relling MV (1999) Science 286: 487–491
Firestein S (2000) Nature 404: 552–553
Frawley WJ, Piatetsky-Shapiro G and Matheus CJ (1992) AI Magazine 13: 57–70.
Gallop MA, Barrett RW, Dower WJ, Fodor SP and Gordon EM (1994) J Med Chem 37: 1233–1251
Gordon EM, Barrett RW, Dower WJ, Fodor SP and Gallop MA (1994) J Med Chem 37: 1385–1401
Hansch C, Leo A and Hoekman D (1995) Exploring QSAR, Volume 1. Fundamentals and Applications in Chemistry and Biology, American Chemical Society, Washington DC
Kauvar LM, Higgins DL, Villar HO, Sportsman JR, Engqvist-Goldstein A, Bukar R, Bauer KE, Dilley H and Rocke DM (1995) Chem Biol 2: 107–118
Kenakin T and Lutz MW (1999) Quantitative Molecular Pharmacology and Informatics in Drug Discovery, Wiley, New York
Lipinski CA, Lombardo F, Dominy BW and Feeney PJ (1997) Adv Drug Delivery Rev 23: 3–25
MacBeath G and Schreiber SL (2000) Science 289: 1760–1763
Schena M (eds) (1999) DNA Microarrays: A Practical Approach, Oxford University Press, NewYork
Scherf U, Ross DT, Waltham M, Smith LH, Lee JK, Tanabe L, Kohn KW, Reinhold WC, Myers TG, Andrews DT, Scudiero DA, Eisen MB, Evans EA, Pommier Y, Botstein D, Brown PO and Weinstein JN (2000) Nature Genetics 24: 236–244
Searls DB (2000) Drug Discovery Today 5: 135–143
Shi LM, Fan Y, Myers TG, O’Connor PM, Paull KD, Friend SH and Weinstein JN (1998a) J Chem Inf Comput Sci 38: 189–199
Shi LM, Myers TG, Fan Y, O’Connor PM, Paull KD, Friend SH and Weinstein JN (1998b) Mol Pharmacol 53: 241–251
Shi LM (1999) The gene chips (DNA microarrays). Web site http://www.gene-chips.com, featured in Science 285: 799
Shi LM, Fang H, Tong W, Wu J, Perkins R, Blair R, Branham W and Sheehan D (2000a) J Chem Inf Comput Sci, submitted
Shi LM, Fan Y, Lee JK, Waltham M, Andrews DT, Scherf U, Paull KD and Weinstein JN (2000b) J Chem Inf Comput Sci 40: 367–379.
Smith CG (1992) The Process of New Drug Discovery and Development. CRC Press, Boca Raton
Southern E, Mir K, Shchepinov M, Nature Genetics. January supplement issue (1999) 21: 1–60.
Weinstein JN, Myers TG, O’Connor PM, Friend SH, Fornace Jr AJ, Kohn KW, Fojo T, Bates SE, Rubinstein LV, Anderson NL, Buolamwini JK, Van Osdol WW, Monks AP, Scudiero DA, Sausville EA, Zaharevitz DW, Bunow B, Viswanadhan VN, Johnson GS, Wittes RE and Paull KD (1997) Science 275: 343–349
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Shi, L.M., Tong, W.D. (2003). Data Mining: An Integrated Approach for Drug Discovery. In: Xing, WL., Cheng, J. (eds) Biochips. Biological and Medical Physics Series. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-05092-7_7
Download citation
DOI: https://doi.org/10.1007/978-3-662-05092-7_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-05585-0
Online ISBN: 978-3-662-05092-7
eBook Packages: Springer Book Archive